Robert Cobuzzi
Chief Operating Officer at CERVOMED INC.
Net worth: - $ as of 2024-03-30
Profile
Robert J.
Cobuzzi is currently the Chief Operating Officer & Director at CervoMed, Inc. He previously served as the President & Chief Executive Officer at Mitocureia, Inc. from 2019 to 2020.
Prior to that, he was the Director-Scientific Licensing & Clinical Program at Adolor Corp.
from 2001 to 2005.
He also held the position of Independent Director at Diffusion Pharmaceuticals, Inc. in 2020.
Additionally, he served as a Director at Par Active Technologies Pvt Ltd.
and held the role of Worldwide Regulatory Affairs at Centocor, Inc. from 1999 to 2001.
From 2005 to 2015, he was the SVP-Operations, Research & Development Strategy at Endo Health Solutions, Inc. and later became the SVP-Corporate Development, R&D, Operations at Endo International Plc from 2005 to 2018.
He was also the President of Endo Ventures Ltd.
from 2015 to 2018.
Furthermore, he held the position of Head-Clinical Operations at Astra Merck, Inc. and was a Member of the US Department of Commerce (District of Columbia).
Dr. Cobuzzi obtained his undergraduate degree from Colby College and his doctorate degree from Loyola University of Chicago.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CERVOMED INC.
-.--% | 2024-01-25 | 0 ( -.--% ) | - $ | 2024-03-30 |
Robert Cobuzzi active positions
| Companies | Position | Start |
|---|---|---|
| CERVOMED INC. | Chief Operating Officer | 2023-08-15 |
Former positions of Robert Cobuzzi
| Companies | Position | End |
|---|---|---|
| Mitocureia, Inc. | Chief Executive Officer | 2020-03-31 |
| ENDO INTERNATIONAL PLC | Chief Operating Officer | 2017-12-31 |
| Endo Ventures Ltd. | President | 2017-12-31 |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Chief Operating Officer | 2014-12-31 |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Corporate Officer/Principal | 2004-12-31 |
Training of Robert Cobuzzi
| Colby College | Undergraduate Degree |
| Loyola University of Chicago | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Health Technology |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
| US Department of Commerce (District of columbia) | Government |
Diffusion Pharmaceuticals, Inc.
 Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. | Health Technology |
Par Active Technologies Pvt Ltd.
 Par Active Technologies Pvt Ltd. Pharmaceuticals: MajorHealth Technology Par Active Technologies Pvt Ltd. manufactures pharmaceutical preparations. The company is headquartered in Kancheepuram, India. | Health Technology |
| Mitocureia, Inc. | |
| CervoMed, Inc. | |
| Endo Ventures Ltd. |
- Stock Market
- Insiders
- Robert Cobuzzi
